Molecular mechanisms of coffee’s antidepressant effects in chronic consumption: A context‑dependent perspective
Acta Neurobiologiae Experimentalis · 13.11.2026
DOI: 10.55782/4sd1qn75 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurobiologiae Experimentalis, online erschienen am 13.11.2026. Verfasst von Mahdiyeh Hedayati-Moghadam und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Coffee, one of the most widely consumed beverages, is associated with reduced depression risk in epidemiological studies. However, the relationship between coffee consumption and mental health is more nuanced than a simple antidepressant effect. This review critically examines the molecular mechanisms by which chronic coffee consumption may influence mood, while emphasizing that these effects depend on dose, timing, genetic variability, metabolic status, sleep, and behavioral context. Key bioactive compounds in coffee—including caffeine, chlorogenic acids, trigonelline, and polyphenols—exert effects through adenosine receptor antagonism, monoamine, anti‑inflammatory actions, brain‑derived neurotrophic factor signaling activation, oxidative stress reduction, hypothalamic‑pituitary‑adrenal axis modulation, gut‑brain axis communication, and metabolic pathway regulation. Importantly, this review distinguishes between coffee‑specific effects and those attributable to caffeine alone, recognizing that coffee contains numerous bioactive compounds beyond caffeine that may contribute to its overall biological activity. The review also critically addresses potential adverse effects, including sleep disruption, anxiety exacerbation, and maladaptive coping patterns, particularly in vulnerable populations such as students, shift workers, and individuals with pre‑existing anxiety disorders. Genetic polymorphisms in CYP1A2 and ADORA2A are discussed as important moderators of caffeine metabolism and sensitivity. The review concludes that while moderate coffee consumption may offer mood‑related benefits under certain conditions, these effects should be interpreted within a conditional risk‑benefit framework rather than as a universal antidepressant property.
Zitieren
APA
Hedayati-Moghadam, M., Heidari, M., Khani, F., Mashayekhi-sardoo, H., Dalfardi, M., Hojatizadeh, Y., & Baghcheghi, Y. (2026). Molecular mechanisms of coffee’s antidepressant effects in chronic consumption: A context‑dependent perspective. Acta Neurobiologiae Experimentalis. https://doi.org/10.55782/4sd1qn75
Vancouver
Hedayati-Moghadam M, Heidari M, Khani F, Mashayekhi-sardoo H, Dalfardi M, Hojatizadeh Y, et al. Molecular mechanisms of coffee’s antidepressant effects in chronic consumption: A context‑dependent perspective. Acta Neurobiologiae Experimentalis. 2026. doi:10.55782/4sd1qn75
BibTeX
@article{HedayatiMoghadam2026,
author = {Hedayati-Moghadam, Mahdiyeh and Heidari, Mojgan and Khani, Fateme and Mashayekhi-sardoo, Habibeh and Dalfardi, Mohammad and Hojatizadeh, Yahya and Baghcheghi, Yousef},
title = {Molecular mechanisms of coffee’s antidepressant effects in chronic consumption: A context‑dependent perspective},
journal = {Acta Neurobiologiae Experimentalis},
year = {2026},
doi = {10.55782/4sd1qn75}
}
EUVIMED